Poseida Therapeutics, Inc.
USD9.50
+0.00 (+0.00%)
CEO
Mark J. Gergen
IPO Date
2020-07-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.58
Prev. Close
$9.50
Day Low
$9.50
Day High
$9.58
52W Low
$1.87
52W High
$9.67
Market Cap
$0.93B
Volume
21.34M
| -6.0 |
| 31 Dec 2021 | FY | -14472.0% | 14097.8% | 2.8% | 1.6% | 0.39 | 4.94 | 96.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 0.9% | 0.7% | 0.23 | 10.46 | 261.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 62.0% | -63.0% | -0.19 | 5.82 | -6.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 57.9% | -98.4% | -0.25 | 2.51 | -12.4 |
| 31 Dec 2017 | FY | 100.0% | -658.7% | 58.6% | -77.2% | -0.29 | 2.18 | -31.0 |
| 31 Dec 2016 | FY | 100.0% | -46.8% | -27.9% | -16.2% | 0.00 | 1.79 | -199.0 |
| -2.3 |
| 31 Mar 2024 | Q1 | 95.1% | -86.3% | -28.7% | -9.2% | 1.00 | 2.56 | -3.1 |
| 31 Dec 2023 | Q4 | 83.3% | -96.0% | -23.1% | -8.8% | 0.82 | 3.18 | -3.2 |
| 30 Sept 2023 | Q3 | 84.6% | -339.8% | -25.7% | -10.5% | 0.70 | 3.28 | -1.7 |
| 30 Jun 2023 | Q2 | 93.0% | -137.2% | -20.3% | -9.8% | 0.64 | 4.61 | -1.4 |
| 31 Mar 2023 | Q1 | 87.2% | -388.7% | -25.5% | -12.8% | 0.56 | 5.35 | -1.7 |
| 31 Dec 2022 | Q4 | 86.3% | -335.8% | -17.8% | -9.5% | 0.47 | 5.54 | -3.4 |
| 30 Sept 2022 | Q3 | 98.8% | 60.5% | 32.5% | 18.5% | 0.42 | 6.64 | 1.0 |
| 30 Jun 2022 | Q2 | 53.3% | -1649.1% | -67.7% | -21.7% | 1.39 | 3.69 | -0.9 |